| Project Optimus is changing the landscape of oncology drug development by redefining dose optimization standards. Learn how ...

In 2025, the CNS market is forecast to surpass $80bn in sales for the first time since 2013, marking a significant turnaround ...

Artificial intelligence (AI) is making significant strides in various fields, with drug discovery being one of the most impactful areas. The process of developing new drugs has traditionally been a ...

A Nigerian pharmaceutical company, ST. RACHEAL’S Pharma, has urged President Bola Tinubu to ensure the return of all ...

In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that consumer prices can be lowered without sacrificing profit margin. Fortunately ...

Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI ...

Commonsense management measures can help keep arthritic horses comfortable and sound even in the coldest weather.

The first is the current packaging, which consists of a box with a big open window that lets customers see what's inside. The ...

Cellares' forward momentum continues, as the company announced April 1, 2025, a notable milestone for its Cell Shuttle.

Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.

Researchers at the University of Missouri have developed an innovative electrochemistry method to create new molecules using ...